| 2.14 0.01 (0.47%) | 04-23 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.86 |
1-year : | 3.16 |
| Resists | First : | 2.45 |
Second : | 2.7 |
| Pivot price | 2.22 |
|||
| Supports | First : | 2.04 |
Second : | 1.7 |
| MAs | MA(5) : | 2.1 |
MA(20) : | 2.24 |
| MA(100) : | 2.2 |
MA(250) : | 2.68 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 10.1 |
D(3) : | 7.2 |
| RSI | RSI(14): 46.7 |
|||
| 52-week | High : | 4.48 | Low : | 1.97 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ KRMD ] has closed above bottom band by 36.3%. Bollinger Bands are 125.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 16 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 2.22 - 2.23 | 2.23 - 2.24 |
| Low: | 2.06 - 2.07 | 2.07 - 2.08 |
| Close: | 2.13 - 2.14 | 2.14 - 2.16 |
KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
Thu, 18 Apr 2024
KORU Medical Systems Inc. (KRMD) Reports Q4 Loss, Misses Revenue Estimates - Yahoo News Canada
Tue, 16 Apr 2024
Short Interest in KORU Medical Systems, Inc. (NASDAQ:KRMD) Grows By 5.6% - MarketBeat
Thu, 11 Apr 2024
KORU Medical Systems Announces Successful Appeal in EU Notified Body Review - Investing.com Nigeria
Thu, 11 Apr 2024
KORU Medical Systems Announces Successful Appeal in EU Notified Body Review - Manchestertimes
Tue, 09 Apr 2024
KORU Medical Systems (NASDAQ:KRMD) Trading Down 1% - MarketBeat
Sat, 30 Mar 2024
Retail investors who hold 36% of KORU Medical Systems, Inc. (NASDAQ:KRMD) gained 12%, institutions profited as well - Simply Wall St
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 47 (M) |
| Shares Float | 32 (M) |
| Held by Insiders | 6.3 (%) |
| Held by Institutions | 57.5 (%) |
| Shares Short | 1,050 (K) |
| Shares Short P.Month | 921 (K) |
| EPS | -0.31 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.44 |
| Profit Margin | -48.2 % |
| Operating Margin | -30.6 % |
| Return on Assets (ttm) | -18.2 % |
| Return on Equity (ttm) | -53.2 % |
| Qtrly Rev. Growth | -2.3 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.61 |
| EBITDA (p.s.) | -0.21 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -5 (M) |
| Levered Free Cash Flow | -2 (M) |
| PE Ratio | -7.14 |
| PEG Ratio | 0 |
| Price to Book value | 4.75 |
| Price to Sales | 3.49 |
| Price to Cash Flow | -20.39 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|